Design, Synthesis, Antibacterial Activity and in Silico Studies of Novel Quinolone Fused with Triazine, Thiadiazole and Oxadiazole Heterocycles

References

• N. C. Desai, K. R. Wadekar, U. P. Pandit, H. K. Mehta, D. J. Jadeja, and M. Pandya, “Design, Synthesis, Biological Evaluation and in-Silico Docking Studies of Some Novel Imidazolone Derivatives as Potent Antimicrobial Containing Fluorine Agents,” Analytical Chemistry Letters 11, no. 4 (2021): 469–96.
   Google Scholar
• I. Althagafi, T. A. Farghaly, E. M. Abbas, and M. F. Harras, “Benzosuberone as Precursor for Synthesis of Antimicrobial Agents: Synthesis, Antimicrobial Activity, and Molecular Docking,” Polycyclic Aromatic Compounds 41, no. 8 (2021): 1646–21.
   Web of Science ®Google Scholar
• N. C. Desai, K. A. Jadeja, D. J. Jadeja, V. M. Khedkar, and P. C. Jha, “Design, Synthesis, Antimicrobial Evaluation, and Molecular Docking Study of Some 4-Thiazolidinone Derivatives Containing Pyridine and Quinazoline Moiety,” Synthetic Communications 51, no. 6 (2020): 1–63.
   Web of Science ®Google Scholar
• W. M. El-Husseiny, “Synthesis and Biological Evaluation of New 3-Phenylthiazolidin-4-One and 3-Phenylthiazole Derivatives as Antimicrobial Agents,” Polycyclic Aromatic Compounds 41, no. 9 (2021): 1988–15.
   Web of Science ®Google Scholar
• N. C. Desai, J. P. Harsora, J. D. Monapara, and V. M. Khedkar, “Synthesis, Antimicrobial Capability and Molecular Docking of Heterocyclic Scaffolds Clubbed by 2-Azetidinone, Thiazole and Quinoline Derivatives,” Polycyclic Aromatic Compounds (2021): 1–5.
   Web of Science ®Google Scholar
• I. Celik, M. Erol, M. O. Puskullu, E. Uzunhisarcikli, U. Ince, G. Kuyucuklu, and S. Suzen, “In Vitro and in Silico Studies of Quinoline-2-Carbaldehyde Hydrazone Derivatives as Potent Antimicrobial Agents,” Polycyclic Aromatic Compounds (2020): 1–17.
   Web of Science ®Google Scholar
• M. H. Shaikh, D. D. Subhedar, S. V. Akolkar, A. A. Nagargoje, V. M. Khedkar, D. Sarkar, and B. B. Shingate, “Tetrazoloquinoline-1, 2, 3-Triazole Derivatives as Antimicrobial Agents: Synthesis, Biological Evaluation and Molecular Docking Study,” Polycyclic Aromatic Compounds (2020): 1–22.
   Web of Science ®Google Scholar
• Gregory S. Basarab, Peter Doig, Charles J. Eyermann, Vincent Galullo, Gunther Kern, Amy Kimzey, Amy Kutschke, Marshall Morningstar, Virna Schuck, Karthick Vishwanathan, et al. “Antibacterial Spiropyrimidinetriones with N-Linked Azole Substituents on a Benzisoxazole Scaffold Targeting DNA Gyrase,” Journal of Medicinal Chemistry 63, no. 20 (2020): 11882–901.
   PubMed Web of Science ®Google Scholar
• N. C. Desai, P. N. Shihora, K. M. Rajpara, V. V. Joshi, H. V. Vaghani, H. M. Satodiya, and A. M. Dodiya, “Synthesis, Characterization, and Antimicrobial Evaluation of Novel Naphthalene-Based 1, 2, 4-Triazoles,” Medicinal Chemistry Research 21, no. 10 (2012): 2981–9.
   Web of Science ®Google Scholar
• C. P. Kaushik, Krishan Kumar, S. K. Singh, Dharmendra Singh, and Sangita Saini, “Synthesis and Antimicrobial Evaluation of 1, 4-Disubstituted 1,2,3-Triazoles with Aromatic Ester Functionality,” Arabian Journal of Chemistry 9, no. 6 (2016): 865–71.
   Web of Science ®Google Scholar
• T. A. Bakka, M. B. Strøm, J. H. Andersen, and O. R. Gautun, “Methyl Propiolate and 3-Butynone: Starting Points for Synthesis of Amphiphilic 1,2,3-Triazole Peptidomimetics for Antimicrobial Evaluation,” Bioorganic & Medicinal Chemistry 25, no. 20 (2017): 5380–95.
   PubMed Web of Science ®Google Scholar
• K. M. Pandya, B. P. Dave, A. H. Patel, R. J. Patel, J. T. Patel, and P. S. Desai, “Synthesis, Pharmacological Evaluation and Structure-Activity Relationship Study of Hydrazones,” Asian Journal of Green Chemistry 4 (2020): 416–33.
   Google Scholar
• N. Singla, G. Singh, R. Bhatia, A. Kumar, R. Kaur, and S. Kaur, “Design, Synthesis and Antimicrobial Evaluation of 1, 3, 4‐Oxadiazole/1, 2, 4‐Triazole‐Substituted Thiophenes,” Chemistry Select 5, no. 13 (2020): 3835–42.
   Google Scholar
• E. Taflan, H. Bayrak, M. Er, ŞA. Karaoğlu, and A. Bozdeveci, “Novel Imidazo[2,1-b][1,3,4]Thiadiazole (ITD) Hybrid Compounds: Design, Synthesis, Efficient Antibacterial Activity and Antioxidant Effects,” Bioorganic Chemistry 89 (2019): 102998.
   PubMed Web of Science ®Google Scholar
• H. Muğlu, N. Şener, H. A. M. Emsaed, S. Özkınalı, O. E. Özkan, and M. Gür, “Synthesis and Characterization of 1, 3, 4-Thiadiazole Compounds Derived from 4-Phenoxybutyric Acid for Antimicrobial Activities,” Journal of Molecular Structure 1174 (2018): 151–9.
   Web of Science ®Google Scholar
• Lidia Lungu, Alexandru Ciocarlan, Crina Smigon, Ilker Ozer, Sergiu Shova, Iacob Gutu, Nicoleta Vornicu, Ionel Mangalagiu, Michele D’Ambrosio, and Aculina Aricu, “Synthesis and Evaluation of Biological Activity of Homodrimane Sesquiterpenoids Bearing 1, 3, 4-Oxadiazole or 1, 3, 4-Thiadiazole Units,” Chemistry of Heterocyclic Compounds 56, no. 5 (2020): 578–85.
   Web of Science ®Google Scholar
• M. Abdel-Motaal, K. Almohawes, and M. A. Tantawy, “Antimicrobial Evaluation and Docking Study of Some New Substituted Benzimidazole-2yl Derivatives,” Bioorganic Chemistry 101 (2020): 103972.
   PubMed Web of Science ®Google Scholar
• X. Lv, L. Yang, Z. Fan, and X. Bao, “Synthesis and Antimicrobial Activities of Novel Quinazolin-4 (3H)-One Derivatives Containing a 1, 2, 4-Triazolo [3, 4-b][1, 3, 4] Thiadiazole Moiety,” Journal of Saudi Chemical Society 22, no. 1 (2018): 101–9.
   Web of Science ®Google Scholar
• M. J. Ahsan, “Rationale Design, Synthesis and in Vitro Anticancer Activity of New 2, 5-Disubstituted-1, 3, 4-Oxadiazole Analogs,” ChemistrySelect 1, no. 15 (2016): 4713–20.
   Web of Science ®Google Scholar
• E. Yarmohammadi, H. Beyzaei, R. Aryan, and A. Moradi, “Ultrasound-Assisted, Low-Solvent and Acid/Base-Free Synthesis of 5-Substituted 1, 3, 4-Oxadiazole-2-Thiols as Potent Antimicrobial and Antioxidant Agents,” Molecular Diversity 25, no. 4 (2021): 2367–78.
   PubMed Web of Science ®Google Scholar
• N. C. Desai, G. M. Kotadiya, A. R. Trivedi, V. M. Khedkar, and P. C. Jha, “Synthesis, Biological Valuation, and QSAR Studies of Novel Pyrazole Bearing Pyridyl Oxadiazole Analogues as Potential Antimicrobial Agents,” Medicinal Chemistry Research 25, no. 4 (2016): 712–27.
   Web of Science ®Google Scholar
• N. C. Desai, A. Trivedi, H. Somani, K. A. Jadeja, D. Vaja, L. Nawale, V. M. Khedkar, and D. Sarkar, “Synthesis, Biological Evaluation, and Molecular Docking Study of Pyridine Clubbed 1, 3, 4-Oxadiazoles as Potential Antituberculars,” Synthetic Communications 48, no. 5 (2018): 524–40.
   Web of Science ®Google Scholar
• K. Kapadiya, G. Dubal, Y. Bhola, and P. Dholaria, “Synthesis and Antimicrobial Evaluation of 1,3,4-Oxadiazole Bearing Schiff Base Moiety,” Asian Journal of Organic & Medicinal Chemistry 5, no. 1 (2020): 1–5.
   Google Scholar
• N. B. Patel, and S. D. Patel, “Synthesis and Antimicrobial Study of Fluoroquinolone-Based 4-Thiazolidinones,” Medicinal Chemistry Research 19, no. 8 (2010): 757–70.
   Web of Science ®Google Scholar
• N. B. Patel, and S. D. Patel, “Synthesis and Antimicrobial Activity of 2-Phenyl-3-{1-Cyclopropyl-6-Fluoro-7-[4-Methylpiperazin-1-yl]-4-Quinolone}Carboxamido-3-Thiazolidin-4-Ones,” Pharmaceutical Chemistry Journal 43, no. 6 (2009): 6.
   Web of Science ®Google Scholar
• N. C. Desai, S. B. Joshi, and V. M. Khedkar, “Synthesis, Antimicrobial Activity and Molecular Docking of Pyrazole Bearing the Benzodiazepine Moiety,” Analytical Chemistry Letters 10, no. 3 (2020): 307–20.
   Google Scholar
• N. C. Desai, D. V. Vaja, K. A. Jadeja, S. B. Joshi, and V. M. Khedkar, “Synthesis, Biological Evaluation and Molecular Docking Study of Pyrazole, Pyrazoline Clubbed Pyridine as Potential Antimicrobial Agents,” Anti-Infective Agents 18, no. 3 (2020): 306–14.
   Google Scholar
• Y. Pommier, “Drugging Topoisomerases: lessons and challenges,” ACS Chemical Biology 8, no. 1 (2013): 82–95.
   PubMed Web of Science ®Google Scholar
• D. E. Ehmann, and S. D. Lahiri, “Novel Compounds Targeting Bacterial DNA Topoisomerase/DNA Gyrase,” Current Opinion in Pharmacology 18 (2014): 76–83.
   PubMed Web of Science ®Google Scholar
• A. Maxwell, and D. M. Lawson, “The ATP-Binding Site of Type II Topoisomerases as a Target for Antibacterial Drugs,” Current Topics in Medicinal Chemistry 3, no. 3 (2003): 283–303.
   PubMed Web of Science ®Google Scholar
• R. A. Friesner, R. B. Murphy, M. P. Repasky, L. L. Frye, J. R. Greenwood, T. A. Halgren, P. C. Sanschagrin, and D. T. Mainz, “Extra Precision Glide: Docking and Scoring Incorporating a Model of Hydrophobic Enclosure for protein-ligand complexes,” Journal of Medicinal Chemistry 49, no. 21 (2006): 6177–96.
   PubMed Web of Science ®Google Scholar
• T. A. Halgren, R. B. Murphy, R. A. Friesner, H. S. Beard, L. L. Frye, W. T. Pollard, and J. L. Banks, “Glide: A New Approach for Rapid, Accurate Docking and Scoring. 2. Enrichment Factors in Database Screening,” Journal of Medicinal Chemistry 47, no. 7 (2004): 1750–9.
   PubMed Web of Science ®Google Scholar
• Richard A. Friesner, Jay L. Banks, Robert B. Murphy, Thomas A. Halgren, Jasna J. Klicic, Daniel T. Mainz, Matthew P. Repasky, Eric H. Knoll, Mee Shelley, Jason K. Perry, et al. “Glide: A New Approach for Rapid, Accurate Docking and Scoring. 1. Method and Assessment of Docking Accuracy,” Journal of Medicinal Chemistry 47, no. 7 (2004): 1739–49.
   PubMed Web of Science ®Google Scholar